-
The centre will help the agri-food industry in B.C. and beyond by providing access to state-of-the-art technologies and facilities.
-
Global COVID-19 treatment trial shows current antivirals are of little benefit to hospitalized patients
Interim results from the Solidarity Therapeutics Trial indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
